R&D | May 02, 2026
Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
Health innovations are viewed more positively than food and agricultural technologies
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
Subscribe To Our Newsletter & Stay Updated
